Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
ARDS
COVID-19 severity
T cell activation
acute respiratory distress syndrome
death versus survival
intracellular death signatures
longitudinal
lung epithelial cells
lung monocyte/macrophages
pancreatic exocrine proteases
plasma proteomics
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
18 05 2021
18 05 2021
Historique:
received:
22
12
2020
revised:
08
03
2021
accepted:
23
04
2021
pubmed:
11
5
2021
medline:
11
5
2021
entrez:
10
5
2021
Statut:
ppublish
Résumé
Mechanisms underlying severe coronavirus disease 2019 (COVID-19) disease remain poorly understood. We analyze several thousand plasma proteins longitudinally in 306 COVID-19 patients and 78 symptomatic controls, uncovering immune and non-immune proteins linked to COVID-19. Deconvolution of our plasma proteome data using published scRNA-seq datasets reveals contributions from circulating immune and tissue cells. Sixteen percent of patients display reduced inflammation yet comparably poor outcomes. Comparison of patients who died to severely ill survivors identifies dynamic immune-cell-derived and tissue-associated proteins associated with survival, including exocrine pancreatic proteases. Using derived tissue-specific and cell-type-specific intracellular death signatures, cellular angiotensin-converting enzyme 2 (ACE2) expression, and our data, we infer whether organ damage resulted from direct or indirect effects of infection. We propose a model in which interactions among myeloid, epithelial, and T cells drive tissue damage. These datasets provide important insights and a rich resource for analysis of mechanisms of severe COVID-19 disease.
Identifiants
pubmed: 33969320
doi: 10.1016/j.xcrm.2021.100287
pii: S2666-3791(21)00115-4
pmc: PMC8091031
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
100287Subventions
Organisme : NIAID NIH HHS
ID : T32 AI007061
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082630
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001102
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA071345
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
A.M. is a consultant for Third Rock Ventures. J.R.G. and I. Gushterova are employees of Olink Proteomics. G.S.H. is an employee of Genentech (as of November 2020). L.L.J. is an employee and stockholder of Novartis. N.H. holds equity in BioNTech and is a consultant for Related Sciences.
Références
J Mucosal Immunol Res. 2018;2(1):
pubmed: 30474083
Eur J Immunol. 2005 Mar;35(3):738-45
pubmed: 15724249
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Sci Adv. 2020 Jul 08;6(28):eaba1983
pubmed: 32832599
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
J Virol. 2004 Oct;78(19):10628-35
pubmed: 15367630
Cell Rep Med. 2020 Jun 23;1(3):100040
pubmed: 32835303
Immunity. 2018 May 15;48(5):1046-1059.e6
pubmed: 29752063
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Nature. 2018 Jun;558(7708):73-79
pubmed: 29875488
Nature. 2020 Jul;583(7817):609-614
pubmed: 32581358
Mol Biol Cell. 2012 Mar;23(6):1129-39
pubmed: 22278742
Nat Med. 2019 Jul;25(7):1153-1163
pubmed: 31209336
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201
pubmed: 33217246
Oncotarget. 2016 Jul 19;7(29):45702-45714
pubmed: 27329720
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759
pubmed: 32663409
Eur J Immunol. 1999 Dec;29(12):3867-76
pubmed: 10601994
Sci Immunol. 2020 Jul 10;5(49):
pubmed: 32651212
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Cell Syst. 2016 Oct 26;3(4):346-360.e4
pubmed: 27667365
Curr Opin Immunol. 2020 Oct;66:74-81
pubmed: 32563779
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Cell Rep Med. 2020 Aug 25;1(5):100078
pubmed: 32838342
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Mol Immunol. 2008 Oct;45(16):4080-3
pubmed: 18706698
Sci Rep. 2018 May 30;8(1):8382
pubmed: 29849057
Crit Care Explor. 2020 Aug 24;2(9):e0189
pubmed: 32904064
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
JAMA Intern Med. 2020 Oct 1;180(10):1356-1362
pubmed: 32808970
JCI Insight. 2019 Jun 18;4(14):e129717
pubmed: 31211695
Science. 2020 Sep 11;369(6509):
pubmed: 32913073
Sci Adv. 2020 Jul 08;6(28):eaba1972
pubmed: 32832598
PLoS One. 2010 Dec 07;5(12):e15004
pubmed: 21165148
JCI Insight. 2020 Mar 26;5(6):
pubmed: 32107344
J Exp Med. 1998 Sep 21;188(6):1135-45
pubmed: 9743532
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Science. 2018 Aug 24;361(6404):769-773
pubmed: 30072576
Cytokine. 2015 Sep;75(1):57-61
pubmed: 26088754
Science. 2016 Apr 15;352(6283):359-62
pubmed: 27013426
Nat Commun. 2020 Dec 9;11(1):6319
pubmed: 33298930
Nat Med. 2019 Dec;25(12):1851-1857
pubmed: 31792462
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32706339
Gastroenterology. 2018 Oct;155(4):1017-1021
pubmed: 30076839
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
Cell. 2020 Dec 10;183(6):1479-1495.e20
pubmed: 33171100
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Circulation. 2020 Aug 4;142(5):466-482
pubmed: 32403949
Cell. 2020 Jun 25;181(7):1475-1488.e12
pubmed: 32479746
Cancer Res. 2006 Apr 15;66(8):4450-60
pubmed: 16618772
Cell Metab. 2013 Aug 6;18(2):287-95
pubmed: 23931759
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
Elife. 2021 Mar 11;10:
pubmed: 33704068
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Cell Syst. 2020 Jul 22;11(1):11-24.e4
pubmed: 32619549
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):
pubmed: 28108486
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Intensive Care Med. 2006 Jun;32(6):910-4
pubmed: 16570150
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Genome Med. 2021 Apr 20;13(1):64
pubmed: 33879239
Mol Ther Nucleic Acids. 2014 Oct 07;3:e201
pubmed: 25291143
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Science. 2015 Sep 11;349(6253):1232-6
pubmed: 26229115
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Immunity. 2020 Nov 17;53(5):1108-1122.e5
pubmed: 33128875
Cell. 2020 Jul 9;182(1):59-72.e15
pubmed: 32492406
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
PLoS One. 2014 Jul 22;9(7):e102347
pubmed: 25051500